TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Apiam Animal Health Ltd. ( (AU:AHX) ) has issued an update.
Apiam Animal Health Ltd. has entered into a binding Scheme Implementation Deed with entities controlled by Adamantem Capital, under which Adamantem’s BidCo will acquire 100% of Apiam’s shares. The proposal offers Apiam shareholders $0.87 cash per share, with alternative options for scrip consideration, representing a significant premium over recent trading prices. The Apiam Independent Board Committee recommends the scheme, highlighting the certainty of value and premium it provides, while recognizing Apiam’s strong market position and growth potential.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Ltd. operates in the animal health industry, providing veterinary services and products across a national network. The company focuses on delivering comprehensive animal health solutions, leveraging its strong market position and growth potential.
Average Trading Volume: 242,236
Technical Sentiment Signal: Buy
Current Market Cap: A$149.9M
Learn more about AHX stock on TipRanks’ Stock Analysis page.